Medical/Pharmaceuticals
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
SAN FRANCISCO and SUZHOU, China, April 25, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmun...
2024-04-25 10:02
2064
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST
SUZHOU, China and ROCKVILLE, Md., April 24, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the co...
2024-04-25 09:02
1586
Breakthrough in Lung Cancer Treatment: Dizal to Unveil Groundbreaking Results of Sunvozertinib for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations at 2024 ASCO Annual Meeting
Topline results from Dizal's global pivotal phase II WU-KONG1 Part B study of sunvozertinib will be showcased in a featured oral presentation at the conference. SHANGHAI, April 24, 2024 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing groundbreaking new med...
2024-04-24 22:10
1769
Future Health highlights greater access to treatment for Mental Health Month
SAN FRANCISCO, April 24, 2024 /PRNewswire/ -- A recent poll
2024-04-24 22:00
1345
Meihua International Medical Technologies Co., Ltd. Reports 2023 Financial Year Results
YANGZHOU, China, April 24, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries inChina, today reported its financial ...
2024-04-24 19:00
2041
Esaote Group: Shareholders' Meeting approves financial statements as of 31 December 2023
* Consolidated revenues up to €273.2 million (+6.5%), EBITDA stands at €41.7 million (+24.5%); EBIT up to €13.4 million and net profit up to €6.2 million. * Sales increased in all business lines, especially in the ultrasound segment (+9.7%). Second consecutive record sales year for MRI (+3.3%...
2024-04-24 18:00
2195
CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
First non-immunosuppressive therapy for the treatment of IgA Nephropathy (IgAN) approved inEurope Conditional marketing authorization is based on statistically significant and clinically meaningful results from the phase-III PROTECT trial ST. GALLEN, Switzerland and SAN DIEGO, April 24, 2024 /PR...
2024-04-24 15:00
2113
Samsung Biologics Reports First Quarter 2024 Financial Results
* Recorded Q1'24 consolidated revenue of KRW 946.9 billion * Recorded Q1'24 consolidated operating profit of KRW 221.3 billion * Sustained growth driven by ongoing strategic expansion in capacity and portfolio INCHEON, South Korea, April 24, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 20794...
2024-04-24 14:45
1631
RELIFE BY A. MENARINI CHAMPIONS PERSONAL CHOICE IN AESTHETIC TREATMENTS, ENCOURAGING SELF-CARE AND SELF-LOVE
- The choice is the individual's hand to treat oneself with love and care, where judgments and negative opinions have no place in personal beauty journeys. KUALA LUMPUR, Malaysia, April 24, 2024 /PRNewswire/ -- RELIFE, the dermatology and aesthetic medicine division of A. Menarini, a wholl...
2024-04-24 10:00
2359
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)
Hanmi Pharmaceutical announces Clinical Trial Collaboration with MSD to evaluate 'BH3120' in combination with KEYTRUDA in phase 1 clinical trial in patients with progressive or metastatic solid tumors SEOUL, South Korea, April 23, 2024 /PRNewswire/ -- Hanmi Pharmaceutical (KOSPI: 128940, CEO:Jae...
2024-04-24 09:27
1330
Significant Case Intake Efficiencies Found in Newly Launched Life Sciences Generative AI Solution
Advanced Intake™ demonstrates up to 65% efficiency gains in adverse case intake and 90% data extraction accuracy and quality BOSTON, April 23, 2024 /PRNewswire/ -- ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, today revealed details about itsAdvanced Inta...
2024-04-23 20:00
1365
Zayed Sustainability Prize's Beyond2020 Initiative Deploys Life-saving Digital Mammograms in Costa Rica
AI-powered mammography services will help detect breast cancer cases among women living in underprivileged communities acrossCosta Rica ABU DHABI, UAE, April 23, 2024 /PRNewswire/ -- Beyond2020, the flagship initiative launched by the Zayed Sustainability Prize, the UAE's pioneering award for su...
2024-04-23 18:39
1721
OSR Holdings and SillaJen have entered into a Memorandum of Understanding to collaboratively pursue the development of innovative therapeutics and enter the U.S. market
SEOUL, South Korea, April 23, 2024 /PRNewswire/ -- OSR Holdings, a global healthcare holding company, announced that it has signed a memorandum of understanding (MOU) with SillaJen, a Kosdaq-listed biotech firm with a pipeline of immuno-oncology drug candidates, to share technology and clinical ...
2024-04-23 18:37
1829
Smartee Showcases Mandibular Repositioning Technology at IDEM Singapore 2024
SINGAPORE, April 23, 2024 /PRNewswire/ -- Smartee Denti-Technology, a global leader in digital orthodontic solutions, proudly announces its successful participation in the International Dental Exhibition and Meeting (IDEM) 2024, held fromApril 19 to April 21 at Marina Bay Sands, Singapore. &...
2024-04-23 16:51
2137
Borsch Med Introduces Chondroitin Supplements to Singapore for Healthy Joints
Chondroitin-based supplements from Zeria Pharmaceutical launched to promote an active lifestyle SINGAPORE, April 23, 2024 /PRNewswire/ -- Borsch Med Pte Ltd (BM), a leading Traditional Chinese Medicine (TCM), Health and Nutrition company based in Singapore, operated and managed by professionals i...
2024-04-23 15:00
1448
HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML)
SAN DIEGO and WUHAN, China, April 23, 2024 /PRNewswire/ -- HanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models" in the N...
2024-04-23 14:54
1278
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
* Vertex obtains an exclusive license to TreeFrog's C-StemTM manufacturing technology in type 1 diabetes * TreeFrog and Vertex to collaborate on scale-up of fully differentiated, insulin-producing pancreatic islet cells BOSTON and BORDEAUX, France, April 23, 2024 /PRNewswire/ -- Vertex Pha...
2024-04-23 12:45
1713
Virtus Fertility Centre Singapore sets up a ReadyBaby Fertility Grant for those facing financial and family planning challenges
This grant is designed to support eligible Singaporean couples in achieving their dream of having a baby, offering them a chance at pregnancy in a private setting. SINGAPORE, April 23, 2024 /PRNewswire/ -- To help married Singaporean couples facing infertility and aspiring to start a family, Vir...
2024-04-23 10:59
1536
Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and Pre-A+ Financing
SHANGHAI, April 22, 2024 /PRNewswire/ -- Brise Pharmaceuticals Co., LTD. (Brise), a pioneering company specializing in innovative treatments for acute and chronic pain, has recently completed Pre-A and Pre-A+ financing with a total of approximately$20 million. This Pre-A round is led by Shunxi F...
2024-04-23 08:00
1530
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024
* Preclinical data from the next generation eyedrop platform to be unveiled for the first time at ARVO 2024 DAEJEON, South Korea, April 22, 2024 /PRNewswire/ -- PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company developing next generation therap...
2024-04-23 07:25
1783
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
7120
